UCB
Brian Neal has extensive experience in the pharmaceutical industry, currently serving as G2M Lead for the Neurology Internal Engine at UCB since June 2016, following roles as Commercialization Lead and Professional Marketing Lead in Immunology. Prior to UCB, Brian Neal worked for Eli Lilly and Company from May 2002 to June 2016, holding positions that included Global Brand Manager for Alzheimer's Dementia and Autoimmune, as well as Consumer Brand Manager in US Diabetes. Brian Neal's career also features roles as a marketing consultant in both Global Diabetes and US Neuroscience, and as a Senior Neuroscience Specialist in Psychiatry. Educationally, Brian Neal holds a Bachelor's Degree in Political Science and English from Mercer University.
This person is not in any teams
This person is not in any offices
UCB
48 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.